Cortivazol

Profil Farmakokinetik

Waktu Paruh (Half-Life) -

Volume Distribusi -

Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1184 Data

Denosumab	The risk or severity of adverse effects can be increased when Denosumab is combined with Cortivazol.
Etanercept	The risk or severity of adverse effects can be increased when Etanercept is combined with Cortivazol.
Peginterferon alfa-2a	The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortivazol.
Interferon alfa-n1	The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Cortivazol.
Interferon alfa-n3	The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortivazol.
Peginterferon alfa-2b	The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortivazol.
Anakinra	The risk or severity of adverse effects can be increased when Anakinra is combined with Cortivazol.
Interferon gamma-1b	The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortivazol.
Interferon alfa-2a	The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Cortivazol.
Adalimumab	The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortivazol.
Gemtuzumab ozogamicin	The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cortivazol.
Pegaspargase	The serum concentration of Cortivazol can be increased when it is combined with Pegaspargase.
Infliximab	The risk or severity of adverse effects can be increased when Infliximab is combined with Cortivazol.
Interferon beta-1b	The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Cortivazol.
Interferon alfacon-1	The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Cortivazol.
Rituximab	The risk or severity of adverse effects can be increased when Rituximab is combined with Cortivazol.
Basiliximab	The risk or severity of adverse effects can be increased when Basiliximab is combined with Cortivazol.
Muromonab	The risk or severity of adverse effects can be increased when Muromonab is combined with Cortivazol.
Ibritumomab tiuxetan	The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Cortivazol.
Tositumomab	The risk or severity of adverse effects can be increased when Tositumomab is combined with Cortivazol.
Alemtuzumab	The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Cortivazol.
Alefacept	The risk or severity of adverse effects can be increased when Alefacept is combined with Cortivazol.
Efalizumab	The risk or severity of adverse effects can be increased when Efalizumab is combined with Cortivazol.
Antithymocyte immunoglobulin (rabbit)	The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Cortivazol.
Interferon alfa-2b	The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Cortivazol.
Daclizumab	The risk or severity of adverse effects can be increased when Daclizumab is combined with Cortivazol.
Phenylalanine	The risk or severity of adverse effects can be increased when Phenylalanine is combined with Cortivazol.
Cladribine	Cortivazol may increase the immunosuppressive activities of Cladribine.
Carmustine	The risk or severity of adverse effects can be increased when Carmustine is combined with Cortivazol.
Amsacrine	The risk or severity of adverse effects can be increased when Amsacrine is combined with Cortivazol.
Bleomycin	The risk or severity of adverse effects can be increased when Bleomycin is combined with Cortivazol.
Chlorambucil	The risk or severity of adverse effects can be increased when Chlorambucil is combined with Cortivazol.
Raltitrexed	The risk or severity of adverse effects can be increased when Raltitrexed is combined with Cortivazol.
Mitomycin	The risk or severity of adverse effects can be increased when Mitomycin is combined with Cortivazol.
Bexarotene	The risk or severity of adverse effects can be increased when Bexarotene is combined with Cortivazol.
Floxuridine	The risk or severity of adverse effects can be increased when Floxuridine is combined with Cortivazol.
Tioguanine	The risk or severity of adverse effects can be increased when Tioguanine is combined with Cortivazol.
Dexrazoxane	The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Cortivazol.
Streptozocin	The risk or severity of adverse effects can be increased when Streptozocin is combined with Cortivazol.
Trifluridine	The risk or severity of adverse effects can be increased when Trifluridine is combined with Cortivazol.
Gemcitabine	The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cortivazol.
Epirubicin	The risk or severity of adverse effects can be increased when Epirubicin is combined with Cortivazol.
Chloramphenicol	The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cortivazol.
Lenalidomide	The risk or severity of adverse effects can be increased when Lenalidomide is combined with Cortivazol.
Altretamine	The risk or severity of adverse effects can be increased when Altretamine is combined with Cortivazol.
Zidovudine	The risk or severity of adverse effects can be increased when Zidovudine is combined with Cortivazol.
Oxaliplatin	The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Cortivazol.
Fluorouracil	The risk or severity of adverse effects can be increased when Fluorouracil is combined with Cortivazol.
Propylthiouracil	The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Cortivazol.
Pentostatin	The risk or severity of adverse effects can be increased when Pentostatin is combined with Cortivazol.
Linezolid	The risk or severity of adverse effects can be increased when Linezolid is combined with Cortivazol.
Clofarabine	The risk or severity of adverse effects can be increased when Clofarabine is combined with Cortivazol.
Pemetrexed	The risk or severity of adverse effects can be increased when Pemetrexed is combined with Cortivazol.
Mycophenolate mofetil	The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Cortivazol.
Tretinoin	The metabolism of Tretinoin can be increased when combined with Cortivazol.
Dacarbazine	The risk or severity of adverse effects can be increased when Dacarbazine is combined with Cortivazol.
Temozolomide	The risk or severity of adverse effects can be increased when Temozolomide is combined with Cortivazol.
Penicillamine	The risk or severity of adverse effects can be increased when Penicillamine is combined with Cortivazol.
Azacitidine	The risk or severity of adverse effects can be increased when Azacitidine is combined with Cortivazol.
Carboplatin	The risk or severity of adverse effects can be increased when Carboplatin is combined with Cortivazol.
Dactinomycin	The risk or severity of adverse effects can be increased when Dactinomycin is combined with Cortivazol.
Azathioprine	The risk or severity of adverse effects can be increased when Azathioprine is combined with Cortivazol.
Hydroxyurea	The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Cortivazol.
Mycophenolic acid	The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Cortivazol.
Topotecan	The risk or severity of adverse effects can be increased when Topotecan is combined with Cortivazol.
Mercaptopurine	The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Cortivazol.
Thalidomide	The risk or severity of adverse effects can be increased when Thalidomide is combined with Cortivazol.
Melphalan	The risk or severity of adverse effects can be increased when Melphalan is combined with Cortivazol.
Fludarabine	The risk or severity of adverse effects can be increased when Fludarabine is combined with Cortivazol.
Flucytosine	The risk or severity of adverse effects can be increased when Flucytosine is combined with Cortivazol.
Capecitabine	The risk or severity of adverse effects can be increased when Capecitabine is combined with Cortivazol.
Procarbazine	The risk or severity of adverse effects can be increased when Procarbazine is combined with Cortivazol.
Arsenic trioxide	The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Cortivazol.
Idarubicin	The risk or severity of adverse effects can be increased when Idarubicin is combined with Cortivazol.
Estramustine	The risk or severity of adverse effects can be increased when Estramustine is combined with Cortivazol.
Mitoxantrone	The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cortivazol.
Lomustine	The risk or severity of adverse effects can be increased when Lomustine is combined with Cortivazol.
Eculizumab	The risk or severity of adverse effects can be increased when Eculizumab is combined with Cortivazol.
Decitabine	The risk or severity of adverse effects can be increased when Decitabine is combined with Cortivazol.
Nelarabine	The risk or severity of adverse effects can be increased when Nelarabine is combined with Cortivazol.
Abatacept	The risk or severity of adverse effects can be increased when Abatacept is combined with Cortivazol.
Stepronin	The risk or severity of adverse effects can be increased when Stepronin is combined with Cortivazol.
Hydroxychloroquine	The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Cortivazol.
Castanospermine	The risk or severity of adverse effects can be increased when Castanospermine is combined with Cortivazol.
Vorinostat	The risk or severity of adverse effects can be increased when Vorinostat is combined with Cortivazol.
2-Methoxyethanol	The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Cortivazol.
Brequinar	The risk or severity of adverse effects can be increased when Brequinar is combined with Cortivazol.
Pirfenidone	The risk or severity of adverse effects can be increased when Pirfenidone is combined with Cortivazol.
Afelimomab	The risk or severity of adverse effects can be increased when Afelimomab is combined with Cortivazol.
Interferon alfa	The risk or severity of adverse effects can be increased when Interferon alfa is combined with Cortivazol.
Glatiramer	The risk or severity of adverse effects can be increased when Glatiramer is combined with Cortivazol.
Briakinumab	The risk or severity of adverse effects can be increased when Briakinumab is combined with Cortivazol.
Human interferon omega-1	The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Cortivazol.
Apremilast	The risk or severity of adverse effects can be increased when Apremilast is combined with Cortivazol.
Canakinumab	The risk or severity of adverse effects can be increased when Canakinumab is combined with Cortivazol.
Tocilizumab	The risk or severity of adverse effects can be increased when Tocilizumab is combined with Cortivazol.
Rilonacept	The risk or severity of adverse effects can be increased when Rilonacept is combined with Cortivazol.
Mepolizumab	The risk or severity of adverse effects can be increased when Mepolizumab is combined with Cortivazol.
Abetimus	The risk or severity of adverse effects can be increased when Abetimus is combined with Cortivazol.
Golimumab	The risk or severity of adverse effects can be increased when Golimumab is combined with Cortivazol.

Target Protein

Glucocorticoid receptor NR3C1

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0

Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.

Deskripsi

Struktur Molekul 2D

Deskripsi metode visualisasi

1. Pendahuluan & Konsep

2. Sumber Data (Validasi)

3. Algoritma Visualisasi

4. Legenda Visual